XENON PHARMACEUTICALS INC. Public Float
XENON PHARMACEUTICALS INC. (XENE) had Public Float of $2.40 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $2.40B.
- 2024-06-30: Entity Public Float $2.95B.
- 2023-06-30: Entity Public Float $2.44B.
- 2022-06-30: Entity Public Float $1.88B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.40B 10-K · filed 2026-02-26 |
| 2024-06-30 | $2.95B 10-K · filed 2025-02-27 |
| 2023-06-30 | $2.44B 10-K · filed 2024-02-29 |
| 2022-06-30 | $1.88B 10-K · filed 2023-03-01 |
| 2021-06-30 | $751.10M 10-K · filed 2022-03-01 |
| 2020-06-30 | $382.90M 10-K · filed 2021-03-01 |
| 2019-06-28 | $227.60M 10-K · filed 2020-03-09 |
| 2018-06-29 | $147.50M 10-K · filed 2019-03-06 |
| 2017-06-30 | $43.40M 10-K · filed 2018-03-07 |
| 2016-06-30 | $81.10M 10-K · filed 2017-03-08 |
| 2015-06-30 | $141.00M 10-K · filed 2016-03-08 |
| 2014-11-05 | $111.00M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |